Key facts
- Leading expert warns UK is a "wild west" for experimental peptides and steroids.
- Patients are increasingly using experimental peptides, with serious health risks.
- Anabolic steroids are known to increase the risk of death threefold.
- Many experimental peptides are manufactured in China, lacking standard quality controls.
- Fitness influencers are using platforms like Telegram to sell these substances.
- There is a growing normalization of enhancement practices across various demographics.
- Regulatory bodies like the MHRA and Advertising Standards Agency have limited scope.
- Government states MHRA investigates illegal sales and the Online Safety Act prioritizes illegal drug sales.
The UK is becoming a "wild west" for the sale and use of experimental peptides and steroids, according to Professor Channa Jayasena of Imperial College London. He stated that he encounters patients daily who are using these substances, warning of serious health risks and potential fatalities due to a lack of regulation and quality control.
Jayasena highlighted that many experimental peptides are manufactured in China without adequate quality checks, increasing the risk of contamination. He also noted that anabolic steroids are known to significantly increase the risk of death. The issue, he explained, is falling between the regulatory stools of bodies like the MHRA and the Advertising Standards Agency, creating a "lawless" environment where potentially dangerous products are normalized.
An investigation by The Guardian revealed that fitness influencers are using social media platforms, such as Telegram, to sell anabolic steroids, prescription-only medicines, and unregulated experimental peptides. Professor Susan Backhouse from Leeds Beckett University observed a broader normalization of enhancement practices, driven by increasing body dissatisfaction among both men and women and constant exposure to idealized images online. She also pointed to the ease of access through online channels and influencer promotion.
Layla Moran, chair of the health select committee, expressed concern over tech firms' disinterest in protecting users and the resource limitations of regulatory agencies. MP Luke Evans, a former GP, echoed these concerns, noting that the online sphere exacerbates the problem and that many users do not perceive themselves as drug users. Evans suggested that addressing the issue requires increased awareness, data collection, and clear accountability.
A government spokesperson affirmed that the UK takes the illegal sale of medicines and harmful substances seriously, with the MHRA's criminal enforcement unit investigating offenses and pursuing prosecutions. The spokesperson also noted that the illegal sale of drugs is a priority under the Online Safety Act.